Last quarter (Q0 0), Livzon Pharmaceutical Group's total revenue was $3.41B, a decrease of -1.90% from the same quarter last year. In Q0, Livzon Pharmaceutical Group's net income was $581.91M. See Livzon Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 12.56B	$ 12.63B	$ 12.06B	$ 10.52B	$ 9.38B	$ 8.86B
Cost of Revenue	$ 4.54B	$ 4.46B	$ 4.25B	$ 3.67B	$ 3.39B	$ 3.36B
Gross Profit	$ 8.02B	$ 8.17B	$ 7.81B	$ 6.85B	$ 5.99B	$ 5.50B
Operating Expense	$ 5.78B	$ 5.93B	$ 5.62B	$ 4.53B	$ 4.41B	$ 4.40B
Operating Income	$ 2.24B	$ 2.23B	$ 2.19B	$ 2.32B	$ 1.80B	$ 1.11B
Net Non Operating Interest Income Expense	$ 182.90M	$ 212.08M	$ 74.32M	$ 145.20M	$ 215.42M	$ 216.32M
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ 2.34B	$ 2.33B	$ 2.25B	$ 2.49B	$ 1.73B	$ 1.42B
Tax Provision	$ 383.92M	$ 375.01M	$ 293.59M	$ 358.11M	$ 265.96M	$ 234.96M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 1.94B	$ 1.91B	$ 1.78B	$ 1.71B	$ 1.30B	$ 1.08B
Basic EPS	$ 2.07	$ 2.04	$ 1.90	$ 1.83	$ 1.39	$ 1.16
Diluted EPS	$ 2.07	$ 2.04	$ 1.90	$ 1.83	$ 1.39	$ 1.16
Basic Average Shares	$ 3.74B	$ 935.98M	$ 934.57M	$ 937.11M	$ 937.32M	$ 932.91M
Diluted Average Shares	$ 3.74B	$ 935.98M	$ 934.57M	$ 937.11M	$ 937.32M	$ 932.91M
Dividend Per Share	$ 1.28	$ 1.28	$ 1.24	$ 0.00	$ 1.20	$ 2.08
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ 2.01	$ 1.74	$ 1.53	$ 1.27	$ 1.02
Reported Normalized Diluted E P S	$ ―	$ 2.01	$ 1.74	$ 1.53	$ 1.27	$ 1.02
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 10.32B	$ 10.40B	$ 9.88B	$ 8.21B	$ 7.80B	$ 7.76B
Net Income From Continuing And Discontinued Operation	$ 1.94B	$ 1.91B	$ 1.78B	$ 1.71B	$ 1.30B	$ 1.08B
Normalized Income	$ 2.08B	$ 2.07B	$ 1.85B	$ 1.71B	$ 1.25B	$ 1.05B
Interest Expense	$ 96.74M	$ 97.55M	$ 84.00M	$ 25.31M	$ 7.26M	$ 16.77M
EBIT	$ 2.44B	$ 2.43B	$ 2.33B	$ 2.51B	$ 1.73B	$ 1.43B
EBITDA	$ 2.44B	$ 3.08B	$ 2.77B	$ 2.91B	$ 2.12B	$ 1.80B

Currency in USD

Livzon Pharmaceutical Group Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing